Molecular Partners Competitors and Similar CompaniesClear all
Molecular Partners's competitors and similar companies include Design Therapeutics and Thor Medical.
 Molecular Partners Molecular Partners is a company that develops biopharmaceutical products for serious diseases. |  Design Therapeutics Design Therapeutics is a biopharmaceutical company engaged the research and development of small-molecule gene targeted chimera therapeutic candidates. |  Thor Medical Thor Medical (formerly known as Nordic Nanovector) is a biopharmaceutical company that focuses on the development and commercialisation of novel targeted therapeutics in haematology and oncology. | |
Founding Date | Founding Date 2004 | Founding Date 2017 | Founding Date 2009 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Zürich-Schlieren, CH HQ Cambridge, US Concord, US | Locations Carlsbad, US HQ | Locations Oslo, NO HQ Zug, CH Shrewsbury, GB |
Employees | Employees 158 | Employees 54 | Employees 3716% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 313.1 m | Valuation ($) 131.4 m |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) kr439k (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit kr4.3m (FY, 2025) |
Net income | Net income (CHF61.7m) (FY, 2025) | Net income ($69.8m) (FY, 2025) | Net income (kr58m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Design Therapeutics
HQ
Carlsbad, US
Employees
54
Design Therapeutics is a biopharmaceutical company engaged the research and development of small-molecule gene targeted chimera therapeutic candidates.
View companyThor Medical
HQ
Oslo, NO
Employees
37↓ 16% decrease
Thor Medical (formerly known as Nordic Nanovector) is a biopharmaceutical company that focuses on the development and commercialisation of novel targeted therapeutics in haematology and oncology.
View company